Therefore, we performed this meta-analysis to identify studies from published literature and to evaluate whether expression of CXCR4 in patients with osteosarcoma can be a suitable prognostic and histopathological marker in the correlation to overall survival and clinicopathological features. Here, CXCR4 is linked to osteosarcoma.